It has a neuroendocrine pathway independent of the GLP-1 receptors, working by stimulating melanocortin-4 receptors (MC4R) to reduce hunger and increase basal metabolic rate
Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by glutathione reductase
, NO, ONOO , and LPO but lower concentrations of H 2 O 2 , GSH, and GSSG in the amniotic fluid cells, as well as a higher concentration of GSSG in the amniotic fluid
[PMID: 39566843] PubMed record related to this compound for laboratory literature review
If you have diabetes and notice vision changes, contact your ophthalmologist
While mild fatigue during the initial weeks of GLP-1 therapy may resolve as your body adjusts, certain patterns or accompanying symptoms warrant prompt medical evaluation